Search

everythinglearnresearchcommunity

for

Search:↓

One-third of COVID-19 patients had long-term symptoms like hair loss and fatigue, with women, older individuals, blood group B, smokers, and those with more virus exposure at higher risk.

Some recovered COVID-19 patients experience skin, hair, and nail issues, suggesting they need follow-up care.

Men had worse COVID-19 outcomes than women in New York City.

MAIT cells may help fight COVID-19 but also contribute to severe inflammation.

Environmental factors affect reproductive traits by altering the SRD5A1 gene.

Genetic differences affect COVID-19 severity and treatment effectiveness.

A COVID-19 patient had unusual nail discoloration and nail separation possibly due to the virus's effects on small blood vessels.

Certain genes are more active in baby scalp cells and can help grow hair when added to adult mouse skin cells.

Compound 15a was effective in inhibiting 5α-reductase.

More social media use during COVID-19 increased interest in cosmetic procedures.

One in four people still had symptoms like weight loss, hair loss, and fatigue 12-14 weeks after recovering from COVID-19.

Tailoring COVID-19 measures to risk levels in the military improves health and readiness.

During the COVID-19 pandemic in Turkey, the most common skin problem for both kids and adults was acne.

Dermatologists helped identify COVID-19 through skin symptoms and managed skin issues during the pandemic, but more high-quality research is needed.

SIM01 significantly reduced post-COVID symptoms and is safe.

Mesenchymal stem cells show promise in treating COVID-19 by reducing inflammation and aiding recovery, but more research is needed.

Teletrichoscopy is a promising method for diagnosing hair disorders remotely during the COVID-19 pandemic.

Early treatment improved COVID-19 outcomes, and spironolactone helped reduce risks in females with high androgen levels.

Older, obese people with many COVID-19 symptoms are more likely to suffer from severe long-term COVID-19 effects.

Long COVID-19 patients with skin pain might have a nerve condition that responds to a medication called gabapentin.

The Covishield COVID-19 vaccine caused skin-related side effects in 1.23% of the people vaccinated in the study from India.

The effect of GLP-1 RAs on erectile function is unclear and needs more research.

Hair affects self-image and well-being, varying by gender, ethnicity, and country.

77% of recovered COVID-19 patients in Nepal experienced long-term symptoms like fatigue, hair loss, and breathing issues.

Blocking Janus kinase 1 helps stop inflammation and regrow hair, making it a good treatment for hair loss from alopecia areata.

18% of COVID-19 survivors experience PTSD, with risk factors including age, gender, smoking, and lung damage.

Long-lasting COVID-19 symptoms like fatigue and breathing difficulties can persist for over 60 days, requiring ongoing care.

Hydroxychloroquine, nitazoxanide, and ivermectin were similarly effective in treating early COVID-19.

Early treatment with certain drug combinations improved COVID-19 outcomes and prevented severe disease in males, including those at higher risk.